Profil
Frédérique Welgryn is currently the Chief Strategic Operations & Innovation Officer at HRA Pharma Development SARL. Previously, she worked as a Director at YSOPIA Biosciences SA, a Manager-Sales & Marketing at Sanofi, and a Manager-Sales & Marketing at AstraZeneca SAS.
Postes actifs de Frédérique Welgryn
| Sociétés | Poste | Début |
|---|---|---|
HRA Pharma Development SARL
HRA Pharma Development SARL Pharmaceuticals: MajorHealth Technology Develops medicines and products for women's health and endocrinology | Corporate Officer/Principal | 01/11/2012 |
Anciens postes connus de Frédérique Welgryn
| Sociétés | Poste | Fin |
|---|---|---|
AstraZeneca SAS
AstraZeneca SAS Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and commercializes pharmaceutical products | Sales & Marketing | - |
| SANOFI | Sales & Marketing | - |
YSOPIA Biosciences SA
YSOPIA Biosciences SA BiotechnologyHealth Technology Develops therapeutic solutions for metabolic and cardiometabolic disorders | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
AstraZeneca SAS
AstraZeneca SAS Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and commercializes pharmaceutical products | Health Technology |
HRA Pharma Development SARL
HRA Pharma Development SARL Pharmaceuticals: MajorHealth Technology Develops medicines and products for women's health and endocrinology | Health Technology |
YSOPIA Biosciences SA
YSOPIA Biosciences SA BiotechnologyHealth Technology Develops therapeutic solutions for metabolic and cardiometabolic disorders | Health Technology |
















